Decision Aid (DA) for Renal Patients

Recruiting now · Not applicable

Conditions studied: Kidney Tumor, Renal Cancer

In brief

The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.

Key facts

Study ID

NCT05387863

Run by

NYU Langone Health

People needed

40

Starts

2022-09-12

Expected to finish

2026-09-01

Last updated by the study team

2025-12-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter.
• Patients scheduled for standard-of-care clinical exams with the NYU Urology Department

You may not qualify if…

• Stage IV cancer of any type
• Inability to provide informed consent
• Vulnerable subjects will not be recruited

Where it is running

• NYU Langone Health — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.